enzalutamide
astellas,pfizer
['arches']
it's always great speaking with , especially at #asco22. he stopped by to review the findings from the post-hoc analysis of the arches trial for #mhspc. 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.